- Logan, Aaron;
- Logan, AC;
- Zhang, B;
- Narasimhan, B;
- Carlton, V;
- Zheng, J;
- Moorhead, M;
- Krampf, MR;
- Jones, CD;
- Waqar, AN;
- Faham, M
Quantification of minimal residual disease (MRD) following allogeneic hematopoietic cell transplantation (allo-HCT) predicts post-transplant relapse in patients with chronic lymphocytic leukemia (CLL). We utilized an MRD-quantification method that amplifie